MedinCell S.A. (EPA: MEDCL)
France
· Delayed Price · Currency is EUR 18.64
+0.16 (0.87%)
Aug 30, 2024, 5:35 PM CET
MedinCell Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 885.86 | 885.86 | 898.47 | 741.76 | 619.83 | 658.02 | Upgrade
|
| Revenue Growth (YoY) | -1.40% | -1.40% | 21.13% | 19.67% | -5.80% | 7.37% | Upgrade
|
| Cost of Revenue | 561.29 | 561.29 | 612.83 | 467.87 | 357.45 | 417.75 | Upgrade
|
| Gross Profit | 324.57 | 324.57 | 285.64 | 273.89 | 262.38 | 240.27 | Upgrade
|
| Selling, General & Admin | 178.57 | 178.57 | 165.96 | 152.24 | 134.91 | 133.58 | Upgrade
|
| Other Operating Expenses | 6.47 | 6.47 | 12.39 | 4.77 | 7.45 | 6.6 | Upgrade
|
| Operating Expenses | 226.02 | 226.02 | 215.3 | 193.52 | 176.7 | 173.21 | Upgrade
|
| Operating Income | 98.55 | 98.55 | 70.34 | 80.37 | 85.68 | 67.06 | Upgrade
|
| Interest Expense | -1.12 | -1.12 | -0.74 | -0.81 | -0.58 | -0.8 | Upgrade
|
| Interest & Investment Income | 2.16 | 2.16 | 0.41 | 0.1 | 0.12 | 0.25 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.44 | 1.44 | -0.35 | 0.19 | -0.66 | 0.25 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.49 | -0.49 | -0.39 | -0.45 | -0.27 | -0.26 | Upgrade
|
| EBT Excluding Unusual Items | 100.54 | 100.54 | 69.28 | 79.4 | 84.29 | 66.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.05 | 0.05 | -0 | -0.07 | -0.25 | -0.02 | Upgrade
|
| Legal Settlements | - | - | - | - | - | 0.22 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.68 | Upgrade
|
| Pretax Income | 100.59 | 100.59 | 69.27 | 79.33 | 84.04 | 67.05 | Upgrade
|
| Income Tax Expense | 24.63 | 24.63 | 17.29 | 20.53 | 21.63 | 21.16 | Upgrade
|
| Earnings From Continuing Operations | 75.96 | 75.96 | 51.98 | 58.8 | 62.41 | 45.89 | Upgrade
|
| Minority Interest in Earnings | -0.53 | -0.53 | -0.99 | -0.74 | -0.39 | -0.2 | Upgrade
|
| Net Income | 75.43 | 75.43 | 50.99 | 58.05 | 62.02 | 45.7 | Upgrade
|
| Net Income to Common | 75.43 | 75.43 | 50.99 | 58.05 | 62.02 | 45.7 | Upgrade
|
| Net Income Growth | 47.92% | 47.92% | -12.16% | -6.39% | 35.71% | 26.66% | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 | 18 | Upgrade
|
| Shares Change (YoY) | 0.01% | 0.01% | -0.01% | 0.01% | -0.00% | -0.01% | Upgrade
|
| EPS (Basic) | 4.08 | 4.08 | 2.76 | 3.14 | 3.36 | 2.47 | Upgrade
|
| EPS (Diluted) | 4.08 | 4.08 | 2.76 | 3.14 | 3.36 | 2.47 | Upgrade
|
| EPS Growth | 47.90% | 47.90% | -12.14% | -6.41% | 35.83% | 26.67% | Upgrade
|
| Free Cash Flow | 110.15 | 110.15 | 8.32 | 36.73 | 70.1 | 56.62 | Upgrade
|
| Free Cash Flow Per Share | 5.96 | 5.96 | 0.45 | 1.99 | 3.79 | 3.06 | Upgrade
|
| Dividend Per Share | 1.100 | 1.100 | 0.800 | 0.750 | 0.900 | 0.300 | Upgrade
|
| Dividend Growth | 37.50% | 37.50% | 6.67% | -16.67% | 200.00% | -50.00% | Upgrade
|
| Gross Margin | 36.64% | 36.64% | 31.79% | 36.92% | 42.33% | 36.51% | Upgrade
|
| Operating Margin | 11.12% | 11.12% | 7.83% | 10.83% | 13.82% | 10.19% | Upgrade
|
| Profit Margin | 8.51% | 8.51% | 5.68% | 7.83% | 10.01% | 6.94% | Upgrade
|
| Free Cash Flow Margin | 12.43% | 12.43% | 0.93% | 4.95% | 11.31% | 8.60% | Upgrade
|
| EBITDA | 136.24 | 136.24 | 104.85 | 113.34 | 117.21 | 96.01 | Upgrade
|
| EBITDA Margin | 15.38% | 15.38% | 11.67% | 15.28% | 18.91% | 14.59% | Upgrade
|
| D&A For EBITDA | 37.69 | 37.69 | 34.51 | 32.97 | 31.53 | 28.96 | Upgrade
|
| EBIT | 98.55 | 98.55 | 70.34 | 80.37 | 85.68 | 67.06 | Upgrade
|
| EBIT Margin | 11.12% | 11.12% | 7.83% | 10.83% | 13.82% | 10.19% | Upgrade
|
| Effective Tax Rate | 24.48% | 24.48% | 24.96% | 25.88% | 25.74% | 31.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.